EDIT Message Board Post 9191020 | Editas Medicine Inc.
home / stock / edit / edit message board
signat1047
(investorshub)
Posted on: Dec/21/2020 16:45:59
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=160368291
Good call on the Short Squeeze. I've
News, Short Squeeze, Breakout and More Instantly...
-
CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a clinical-stage gene editing company, today announced ...
-
CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced that two abstracts, including one oral presentation and one poster presentation, detailing clinical data from the RUBY and EdiTHAL trials of renizga...
-
Research includes the first-ever application of AsCas12a in vivo, optimized LNP delivery, and gene editing RNA guide modifications Data to support...